Advertisement

Structural and Mechanistic Studies on Klebsiella pneumoniae 2-Oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline Decarboxylase.

03:49 EDT 20th June 2013 | BioPortfolio

Summary of "Structural and Mechanistic Studies on Klebsiella pneumoniae 2-Oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline Decarboxylase."

The stereospecific oxidative degradation of uric acid to (S)-allantoin was recently shown to proceed via three enzymatic steps. The final conversion is a decarboxylation of the unstable intermediate 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline (OHCU) and is catalyzed by OHCU decarboxylase. Here we present the structures of Klebsiella pneumoniae OHCU decarboxylase in unliganded form and with bound allantoin. These structures provide evidence that ligand binding organizes the active site residues for catalysis. Modeling of the substrate and intermediates provides additional support for this hypothesis. In addition we characterize the steady state kinetics of this enzyme and report the first OHCU decarboxylase inhibitor, allopurinol, a structural isomer of hypoxanthine. This molecule is a competitive inhibitor of K. pneumoniae OHCU decarboxylase with a K(i) of 30 ± 2 μm. Circular dichroism measurements confirm structural observations that this inhibitor disrupts the necessary organization of the active site. Our structural and biochemical studies also provide further insights into the mechanism of catalysis of OHCU decarboxylation.

Affiliation

From the Department of Chemistry and Chemical Biology, Cornell University, Ithaca, New York 14853.

Journal Details

This article was published in the following journal.

Name: The Journal of biological chemistry
ISSN: 1083-351X
Pages: 35446-54

Links

Medical and Biotech [MESH] Definitions

3-isopropylmalate Dehydrogenase

An NAD+ dependent enzyme that catalyzes the oxidation of 3-carboxy-2-hydroxy-4-methylpentanoate to 3-carboxy-4-methyl-2-oxopentanoate. It is involved in the biosynthesis of VALINE; LEUCINE; and ISOLEUCINE.

Klebsiella Pneumoniae

Gram-negative, non-motile, capsulated, gas-producing rods found widely in nature and associated with urinary and respiratory infections in humans.

Enterobacter Aerogenes

Gram-negative, capsulated, gas-producing rods found widely in nature. Both motile and non-motile strains exist. The species is closely related to KLEBSIELLA PNEUMONIAE and is frequently associated with nosocomial infections

Klebsiella Infections

Infections with bacteria of the genus KLEBSIELLA.

2-hydroxy-5-nitrobenzyl Bromide

A chemical reagent that reacts with and modifies chemically the tryptophan portion of protein molecules. Used for 'active site' enzyme studies and other protein studies. Sometimes referred to as Koshland's reagent.

PubMed Articles [ 11749 Associated PubMed Articles listed on BioPortfolio]

Structural and kinetic insights into the mechanism of 5-hydroxyisourate hydrolase from Klebsiella pneumoniae.

The stereospecific oxidative degradation of uric acid to (S)-allantoin has recently been demonstrated to proceed via two unstable intermediates and requires three separate enzymatic reactions. The se...

Draft Genome Sequence of Klebsiella pneumoniae subsp. pneumoniae DSM 30104T.

Klebsiella pneumoniae is a Gram-negative, rod-shaped, nonmotile, and opportunistic pathogenic species with clinical importance. It is a part of natural flora of humans and animals. Here we report the...

Community-acquired Klebsiella pneumoniae liver abscess: an emerging infection in Ireland and Europe.

INTRODUCTION: Klebsiella pneumoniae has emerged as a predominant cause of community-acquired mono-microbial pyogenic liver abscess. This was first described in Taiwan and has been widely reported in A...

bla(OXA-181)-positive Klebsiella pneumoniae, Singapore.

TO THE EDITOR: Nordmann et al. (1) raised concern over the global spread of carbapenemase-producing Enterobacteriaceae. In their article, they called attention to the oxacillinase-48 (OXA-48) type car...

Successful treatment of endogenous Klebsiella pneumoniae endophthalmitis: a case report.

Background Klebsiella pneumoniae endophthalmitis is rare and despite immediate management, visual outcome is generally poor. We report a case of endogenous K. pneumoniae endophthalmitis that was treat...

Clinical Trials [ 705 Associated Clinical Trials listed on BioPortfolio]

Selective Digestive Decontamination in Carriers of Carbapenem-Resistant Klebsiella Pneumoniae

There is an urgent need to control our current national outbreak of carbapenem-resistant Klebsiella pneumoniae (CRKP). The purpose of this study is to eradicate CRKP gastrointestinal carri...

Klebsiella Pneumoniae Necrotizing Fasciitis: Clinical and Microbiological Features

This is a retrospective descriptive study on the clinical and microbiological features of Klebsiella Pneumoniae Necrotizing Fasciitis.

Efficacy and Safety of Colistin for Therapy of Infections Caused by ESBL Producing K.Pneumoniae or E.Coli

In patients with documented ESBL-producing E.coli and Klebsiella pneumoniae will be allocated to receive colistin or conventional antibiotic regimen.

Risk Factors for Quinolone Resistance Among ESBL Producing Klebsiella Species

This is a retrospective chart review. This proposed study aims to document the risk factors for quinolone resistance in bloodstream isolates of Klebsiella species. Additionally, the adequ...

Nasopharyngeal Streptococcus Pneumoniae Carriage

Primary Objective: Evaluation of the - Carriage rate of Streptococcus pneumoniae in the nasopharynx of children Secondary Objective: - Carriage rate and distribution of Strepto...

Search BioPortfolio:
Advertisement
Advertisement

Latest Biotech, Pharma and Healthcare News

Pharmaceutical Research: Brain Disposition and Catalepsy After Intranasal Delivery of Loxapine: Role of Metabolism in PK/PD of Intranasal CNS Drugs

FDA Grants Diazyme 510(k) Clearance to Market Its New 25-Hydroxy Vitamin D Enzyme Immunoassay

Rempex Pharmaceuticals to Present Data at ICAAC on Carbavance™, a New Agent Designed to Treat Multi-Drug Resistant (MDR) Gram-Negative Bacteria

The AAPS Journal: Dose Selection Based on Physiologically Based Pharmacokinetic (PBPK) Approaches

Rib-X Reports Preclinical Studies at ICAAC with Novel Classes of RX-04 Antibiotic Compounds Demonstrating Potent and Rapid Efficacy in a S. pneumoniae Lung Model of Infection and Activity Against a Diverse Spectrum of Biodefense Pathogens

Pharmaceutical Research: Mechanistic Modeling to Predict the Transporter- and Enzyme-Mediated Drug-Drug Interactions of Repaglinide

AAPS PharmSciTech: The Improvement of the Anticancer Effect of a Novel Compound Benzoic Acid, 2-Hydroxy-, 2-d-ribofuranosylhydrazide (BHR) Loaded in Solid Lipid Nanoparticles


Searches Linking to this Article